Alumis (ALMS) Interest Expenses (2023 - 2025)
Alumis' (ALMS) quarterly Interest Expenses came in at $1.9 million in Q4 2025, up 56.91% year-on-year from $1.2 million in Q4 2024, and down 88.77% on a QoQ basis from $17.1 million in Q3 2025.
Alumis (ALMS) Interest Expenses (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Interest Expenses data on file, last reported at $1.9 million in Q4 2025.
- On a quarterly basis, Interest Expenses rose 56.91% year-over-year to $1.9 million in Q4 2025; TTM through Dec 2025 was $5.7 million, a 24.53% increase from a year earlier, with the FY2025 full-year figure at $293.0 million, up 2376.15% from the prior year.
- Interest Expenses for Q4 2025 stood at $1.9 million, down from $17.1 million in the prior quarter.
- Over the last five years, Interest Expenses for ALMS reached as high as $56.9 million in Q2 2025 and fell as low as $805000.0 in Q3 2023.
- Historically, Interest Expenses has averaged $14.1 million across 3 years, with a median of $3.5 million in 2025.
- Across the five-year window, Interest Expenses surged 6060.5% in 2024 and slumped 65.55% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $1.2 million in 2023, then increased by 5.16% to $1.2 million in 2024, then surged by 56.91% to $1.9 million in 2025.
- Per Business Quant data, the three most recent Interest Expenses figures were $1.9 million in Q4 2025, $17.1 million in Q3 2025, and $56.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - | 1.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.92 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Sep 30, 2025 | 17.08 Mn |
| Sep 30, 2025 | 17.08 Mn |
| Jun 30, 2025 | 56.92 Mn |
| Jun 30, 2025 | 56.92 Mn |
| Mar 31, 2025 | 5.09 Mn |
| Mar 31, 2025 | 5.09 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 49.59 Mn |
| Sep 30, 2024 | 49.59 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 805,000.00 |
| Sep 30, 2023 | 805,000.00 |